Chronic Liver Disease: New Targets and Mechanisms
Abstract & Details
Research Area
Pharmacy
Keywords
inflammation
fibrosis
and progressive dysfunction
Chronic liver disease (CLD)
Abstract
Chronic liver disease (CLD) is a major global health concern, characterized by persistent liver inflammation, fibrosis, and progressive dysfunction. Despite advancements in understanding the pathophysiology of liver diseases, the therapeutic options remain limited. Recent research has uncovered novel molecular pathways, signaling networks, and cellular mechanisms involved in the progression of CLD, offering potential new therapeutic targets. These mechanisms include immune dysregulation, hepatic stellate cell activation, alterations in gut-liver axis, and the role of non-coding RNAs in disease progression. Additionally, emerging targets such as fibrosis biomarkers, inflammatory cytokines, and cellular senescence pathways provide exciting opportunities for early intervention and personalized treatment strategies. This review highlights the latest discoveries in chronic liver disease research, emphasizing innovative molecular targets, their therapeutic potential, and the challenges in translating these findings into clinical practice. Understanding these mechanisms could pave the way for novel treatments that effectively halt or reverse the progression of chronic liver disease, ultimately improving patient outcomes and quality of life.
License
This work is licensed under a Creative
Commons
Attribution-ShareAlike 4.0 International License.
Author Information
| # | Name | Institute / Affiliation |
|---|---|---|
| 1 | Emmanuela John Sima | Rayat Bahra University Mohali, Punjab |
| 2 | Shivani Sharma | Rayat Bahra University Mohali, Punjab |
| 3 | Diksha Sharma | Rayat Bahra University Mohali, Punjab |
| 4 | Anchal Dhawan | Rayat Bahra University Mohali, Punjab |
How to Cite
Use the following formats to cite this article in your research.
APA Style
Sima, Emmanuela John, Sharma, Shivani, Sharma, Diksha, & Dhawan, Anchal (2025). Chronic Liver Disease: New Targets and Mechanisms. International Journal of Advance Research and Innovative Ideas In Education, 11(2), 656-663.
MLA Style
Sima, Emmanuela John, et al. "Chronic Liver Disease: New Targets and Mechanisms." International Journal of Advance Research and Innovative Ideas In Education, vol. 11, no. 2, 2025, pp. 656-663.
IEEE Style
Emmanuela John Sima, Shivani Sharma, Diksha Sharma, and Anchal Dhawan, "Chronic Liver Disease: New Targets and Mechanisms," International Journal of Advance Research and Innovative Ideas In Education, vol. 11, no. 2, pp. 656-663, 2025.
Vancouver Style
Sima Emmanuela John, Sharma Shivani, Sharma Diksha, Dhawan Anchal. Chronic Liver Disease: New Targets and Mechanisms. International Journal of Advance Research and Innovative Ideas In Education. 2025;11(2):656-663.
Harvard Style
Sima, Emmanuela John, Sharma, Shivani, Sharma, Diksha, & Dhawan, Anchal (2025) 'Chronic Liver Disease: New Targets and Mechanisms', International Journal of Advance Research and Innovative Ideas In Education, 11(2), pp. 656-663.
Chicago Style
Sima, Emmanuela John, et al. "Chronic Liver Disease: New Targets and Mechanisms." International Journal of Advance Research and Innovative Ideas In Education 11, no. 2 (2025): 656-663.
Turabian Style
Sima, Emmanuela John, et al. "Chronic Liver Disease: New Targets and Mechanisms." International Journal of Advance Research and Innovative Ideas In Education 11, no. 2 (2025): 656-663.
Related Research
FORMULATION AND EVALUATION OF MUCOADHESIVE MICROSPHERE DRUG DELIVERY SYSTEM OF LOSARTAN
Download PDF
Formulation and Characterization of Nanoparticle Based Systems for Enhanced Oral Delivery of Acalabrutinib
Download PDF
Formulation and Evaluation of Solid-Self Nano Emulysifying Drug Delivery System of poorly soluble drug Rosuvastatin for increased its bioavailability
Download PDF
Formulation, Characterization & Evaluation of Polymeric Amorphous Films of Itraconazole by Using Cellulosic Polymers
Download PDF